Company intelligence / Profile preview
Salud Integral
- Ownership
- Private
- Development stage
- Other
Overview
Salud Integral produces Anvirzel® and AdelfaRx, oleander-based therapies manufactured in a GMP-certified lab. AdelfaRx is approved for sale in Honduras but not in the US, and used for oncology and immunology indications. Clinical results are not published; safety/efficacy remains unverified in peer-reviewed trials.
- Therapeutic areas
- OncologyInfectious DiseasesImmunology
- Modalities
- Small moleculePlant-derived product
- Industry
- Biotech
Drug pipeline
1 assetPartnerships
Beyond the preview
Go deeper on Salud Integral.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Salud Integral.